← FDA DRUG APPROVALS

FDA ANDA · ANDA090283

FAMOTIDINE

Sponsor: SUN PHARM INDS LTD

APPLICATION
ANDA090283
TYPE
ANDA
ORIGINAL APPROVAL
2009-11-17
LATEST ACTION
2020-05-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

FAMOTIDINEDiscontinued
FAMOTIDINE 10MG · TABLET · ORAL
FAMOTIDINEDiscontinued
FAMOTIDINE 20MG · TABLET · ORAL

Approval history

2020-05-11Labeling · Supplement 12 · standardAP
2015-09-02Labeling · Supplement 2AP
2009-11-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →